Business Segments · Revenue
Cost of product sold — Revenue
Cardinal Health Cost of product sold — Revenue decreased by 3.4% to $3.15B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.4%, from $3.16B to $3.15B. Over 2 years (FY 2022 to FY 2025), Cost of product sold — Revenue shows relatively stable performance with a -2.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ3 2021
Last reportedQ1 2026
Rolls up toTotal Revenue
How to read this metric
Higher revenue indicates strong market demand and effective sales execution within the segment.
Detailed definition
This metric represents the total revenue generated by the cost of product sold segment. It captures the gross inflow of...
Peer comparison
Comparable to segment-level revenue reporting for pharmaceutical distribution divisions at peer companies.
Metric ID:
cah_segment_cost_of_product_sold_revenueHistorical Data
16 periods
| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.32B | $3.32B | $3.32B | $3.32B | $2.99B | $3.03B | $3.13B | $3.11B | $3.11B | $3.12B | $3.15B | $3.16B | $3.20B | $3.18B | $3.26B | $3.15B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -10.0% | +1.4% | +3.1% | -0.4% | -0.1% | +0.5% | +1.0% | +0.2% | +1.2% | -0.5% | +2.4% | -3.4% |
| YoY Change | — | — | — | — | -10.0% | — | — | +4.1% | — | +3.0% | +0.9% | +1.5% | +2.9% | +2.0% | +3.3% | -0.4% |
Range$2.99B – $3.32B
CAGR-1.4%
Avg YoY Growth+0.8%
Median YoY Growth+2.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Cardinal Health's cost of product sold — revenue?
- Cardinal Health (CAH) reported cost of product sold — revenue of $3.15B in Q1 2026.
- How has Cardinal Health's cost of product sold — revenue changed year-over-year?
- Cardinal Health's cost of product sold — revenue decreased by 0.4% year-over-year, from $3.16B to $3.15B.
- What is the long-term trend for Cardinal Health's cost of product sold — revenue?
- Over 2 years (2022 to 2025), Cardinal Health's cost of product sold — revenue has grown at a -2.5% compound annual growth rate (CAGR), from $13.28B to $12.64B.
- What does cost of product sold — revenue mean?
- Total sales revenue attributed to the cost of product sold segment.